253 related articles for article (PubMed ID: 22617153)
1. The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis.
Kim SU; Oh HJ; Wanless IR; Lee S; Han KH; Park YN
J Hepatol; 2012 Sep; 57(3):556-63. PubMed ID: 22617153
[TBL] [Abstract][Full Text] [Related]
2. Early on-treatment change in liver stiffness predicts development of liver-related events in chronic hepatitis B patients receiving antiviral therapy.
Kim BK; Oh HJ; Park JY; Kim DY; Ahn SH; Han KH; Park Y; Yoo EJ; Park YN; Kim SU
Liver Int; 2013 Feb; 33(2):180-9. PubMed ID: 23295050
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
4. Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma.
Kim SU; Jung KS; Lee S; Park JY; Kim DY; Ahn SH; Choi GH; Kim KS; Choi JS; Han KH; Park YN
Liver Int; 2014 Aug; 34(7):1008-17. PubMed ID: 24483989
[TBL] [Abstract][Full Text] [Related]
5. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy.
Bruno S; Saibeni S; Bagnardi V; Vandelli C; De Luca M; Felder M; Fracanzani AL; Prisco C; Vitaliani G; Simone L; Gaeta GB; Stanzione M; Persico M; Furlan C; Stroffolini T; Salerno F; Maisonneuve P; Almasio PL;
Am J Gastroenterol; 2013 Jul; 108(7):1112-22. PubMed ID: 23732467
[TBL] [Abstract][Full Text] [Related]
6. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
Omran MM; Farid K; Emran TM; Attallah AA
Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
[TBL] [Abstract][Full Text] [Related]
7. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
Kim MY; Cho MY; Baik SK; Park HJ; Jeon HK; Im CK; Won CS; Kim JW; Kim HS; Kwon SO; Eom MS; Cha SH; Kim YJ; Chang SJ; Lee SS
J Hepatol; 2011 Nov; 55(5):1004-9. PubMed ID: 21354227
[TBL] [Abstract][Full Text] [Related]
8. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.
Bruno S; Zuin M; Crosignani A; Rossi S; Zadra F; Roffi L; Borzio M; Redaelli A; Chiesa A; Silini EM; Almasio PL; Maisonneuve P
Am J Gastroenterol; 2009 May; 104(5):1147-58. PubMed ID: 19352340
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
[TBL] [Abstract][Full Text] [Related]
11. Cirrhosis histology and Laennec staging system correlate with high portal pressure.
Rastogi A; Maiwall R; Bihari C; Ahuja A; Kumar A; Singh T; Wani ZA; Sarin SK
Histopathology; 2013 Apr; 62(5):731-41. PubMed ID: 23470026
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
Park MS; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Shin SH; Kang W; Moon C; Han KH
Liver Int; 2015 Feb; 35(2):455-62. PubMed ID: 25183426
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.
Kim MN; Kim SU; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Clin Gastroenterol; 2014 Mar; 48(3):272-8. PubMed ID: 23811938
[TBL] [Abstract][Full Text] [Related]
14. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
15. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Velázquez RF; Rodríguez M; Navascués CA; Linares A; Pérez R; Sotorríos NG; Martínez I; Rodrigo L
Hepatology; 2003 Mar; 37(3):520-7. PubMed ID: 12601348
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
Abdelgawad IA
J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
[TBL] [Abstract][Full Text] [Related]
17. [Prediction of high risk group of patients with hepatitis-C-virus type liver cirrhosis developing to liver neoplasm].
Tarao K; Shimizu A; Okawa S; Tamai S
Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1985-91. PubMed ID: 8586918
[No Abstract] [Full Text] [Related]
18. A comparative study of cirrhosis sub-staging using the Laennec system, Beijing classification, and morphometry.
Zhang X; Schiano TD; Doyle E; Branch AD; Florman S; Fiel MI
Mod Pathol; 2021 Dec; 34(12):2175-2182. PubMed ID: 34381188
[TBL] [Abstract][Full Text] [Related]
19. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
